Calling all media inquiries! Pay attention to our recent findings and give us a call to talk to the expert directly. Contact Liz Moore to schedule some time to get insightful, unbiased, fact-based answers to your questions.
Avalere Health and the Endocrine Society launch hypoglycemia clinical tools.
Restrictive network plans comprise over 75% of the exchange market.
New analysis from Avalere finds that Democratic proposals to expand public programs, such as a public option or single payer, will impact substantially different populations depending on how they are designed.
New analysis from Avalere finds that over 96% of counties with exchanges operated by HealthCare.gov have free plan options for low-income consumers.
Continuing analysis from Avalere finds that state reinsurance programs reduce individual market premiums by 16.9% on average in their first year, relative to estimated premiums without reinsurance.
With the 2020 presidential election nearly 1 year away, healthcare reform remains one of the top issues for voters heading into the election year.
Medicare ACOs continue to realize experience-level results.
Healthcare industry veteran brings decades of Medicare Advantage, Part D, risk adjustment, and business expertise to payer, life sciences, and provider clients.
Cost savings and improved clinical outcomes cited as top advantages for payers according to survey conducted by Avalere Health.
New analysis from Avalere finds that the quantity of retail fentanyl sold across the US dropped by an average of 28%, between 2014 and 2017.
Avalere will serve as the RWJF Health Systems Transformation Research Coordinating Center to meet patients’ interrelated clinical and social needs.
New research from Avalere finds that capped funding policies could reduce federal funding to states, specifically for children, by $89B to $163B nationally for FY 2020–2029.
Dr. Roy Beveridge and Mike Schneider Join the Firm
Dr. Angela Shen Joins the Firm
Final rule by the Treasury Department, Department of Labor, and the Department of Health and Human Services reverses previous Treasury Department guidance blocking tax-advantaged HRAs that were not integrated with a comprehensive employer-sponsored plan.
A new Avalere analysis finds that oncology practices participating in the Oncology Care Model (OCM) treated patients with 2–3% higher Medicare costs per episode, on average, than OCM prediction model estimates during the first two performance periods.
Matt Kazan and Amy Schroeder bring unique understandings of how policy and clinical data drive healthcare markets.
Pressure to lower costs will increase for OCM providers as CMS pushes to 2-sided risk.
Providers in the Bundled Payments for Care Improvement Advanced initiative began to assume financial risk on March 1, 2019.
Christie Teigland, PhD, has been invited to serve on the Pharmacy Quality Alliance (PQA) Executive Research Advisory Council (ERAC).